SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
20-Sep-11 1:02 PM View: | Biberstein Kathryn L SVP, General Counsel | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 32,459 | -- | -- | (100%) 32.46K to 0 | |
20-Sep-11 1:19 PM View: | Frates James M SVP, CFO & Treasurer | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 4,000 | -- | -- | (100%) 4.0K to 0 | |
20-Sep-11 12:46 PM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 24,027 | -- | -- | (100%) 24.03K to 0 | |
20-Sep-11 12:53 PM View: | Ehrich Elliot SVP, R&D & Chief Medical Ofcr | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 18,579 | -- | -- | (100%) 18.58K to 0 | |
20-Sep-11 1:14 PM View: | Wall Michael A Director | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 608,450 | -- | -- | (100%) 608.45K to 0 | |
20-Sep-11 1:00 PM View: | Anstice David W Director | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 10,000 | -- | -- | (100%) 10.0K to 0 | |
20-Sep-11 12:50 PM View: | Pops Richard F President and CEO Director | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 424,354 | -- | -- | (100%) 424.35K to 0 | |
20-Sep-11 12:39 PM View: | Bloom Floyd E Director | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 90,281 | -- | -- | (75%) 120.38K to 30.09K | |
20-Sep-11 12:43 PM View: | Breyer Robert A Director | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 61,131 | -- | -- | (100%) 61.13K to 0 | |
20-Sep-11 1:09 PM View: | Skaletsky Mark B Director | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
20-Sep-11 12:58 PM View: | Mitchell Paul J Director | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 8,000 | -- | -- | (100%) 8.0K to 0 | |
20-Sep-11 1:19 PM View: | Frates James M SVP, CFO & Treasurer | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 74,606 | -- | -- | (95%) 78.61K to 4.0K | |
20-Sep-11 1:25 PM View: | Landine Michael J SVP, Corporate Development | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 149,227 | -- | -- | (100%) 149.23K to 0 | |
20-Sep-11 1:12 PM View: | Rich Alexander Director | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 348,400 | -- | -- | (100%) 348.4K to 0 | |
20-Sep-11 12:39 PM View: | Bloom Floyd E Director | Alkermes, Inc. (ALKS) | 16-Sep-11 | Disposition | 30,094 | -- | -- | (100%) 30.09K to 0 | |
14-Sep-11 4:12 PM View: | Frates James M SVP, CFO & Treasurer | Alkermes, Inc. (ALKS) | 01-Sep-11 | Gift | 10,000 | -- | -- | (11%) 88.61K to 78.61K | |
12-Sep-11 6:20 PM View: | Bloom Floyd E Director | Alkermes, Inc. (ALKS) | 25-Aug-11 | Gift | 9,028 | -- | -- | 7% 120.38K to 129.4K | |
12-Sep-11 6:20 PM View: | Bloom Floyd E Director | Alkermes, Inc. (ALKS) | 25-Aug-11 | Gift | 9,028 | -- | -- | (7%) 129.4K to 120.38K | |
12-Sep-11 6:20 PM View: | Bloom Floyd E Director | Alkermes, Inc. (ALKS) | 24-Aug-11 | Gift | 21,066 | -- | -- | 18% 120.38K to 141.44K | |
12-Sep-11 6:20 PM View: | Bloom Floyd E Director | Alkermes, Inc. (ALKS) | 24-Aug-11 | Gift | 21,066 | -- | -- | (15%) 141.44K to 120.38K | |
19-Jul-11 4:17 PM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 18-Jul-11 | Market Option Sale (Planned) | 12,000 | $19.01 | $228,070.00 | (33%) 36.03K to 24.03K | (50%) |
19-Jul-11 4:17 PM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 18-Jul-11 | Option Exercise | 12,000 | $7.36 | $88,320.00 | 50% 24.03K to 36.03K | |
12-Jul-11 4:51 PM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 08-Jul-11 | Payment of Exercise | 1,588 | $19.52 | $30,997.80 | (6%) 25.61K to 24.03K | (46%) |
12-Jul-11 4:45 PM View: | Frates James M SVP, CFO & Treasurer | Alkermes, Inc. (ALKS) | 08-Jul-11 | Market Option Sale (Planned) | 200 | $20.00 | $4,000.00 | (< 1%) 88.81K to 88.61K | (42%) |
12-Jul-11 4:45 PM View: | Frates James M SVP, CFO & Treasurer | Alkermes, Inc. (ALKS) | 08-Jul-11 | Payment of Exercise | 1,588 | $19.52 | $30,997.80 | (2%) 90.39K to 88.81K | (46%) |
12-Jul-11 4:49 PM View: | Landine Michael J SVP, Corporate Development | Alkermes, Inc. (ALKS) | 08-Jul-11 | Payment of Exercise | 2,062 | $19.52 | $40,250.20 | (1%) 151.29K to 149.23K | (46%) |
12-Jul-11 4:45 PM View: | Frates James M SVP, CFO & Treasurer | Alkermes, Inc. (ALKS) | 08-Jul-11 | Option Exercise | 200 | $4.77 | $954.00 | < 1% 90.19K to 90.39K | |
12-Jul-11 4:53 PM View: | Pops Richard F President and CEO Director | Alkermes, Inc. (ALKS) | 08-Jul-11 | Payment of Exercise | 4,175 | $19.52 | $81,496.00 | (< 1%) 428.53K to 424.35K | (46%) |
12-Jul-11 4:47 PM View: | Biberstein Kathryn L SVP, General Counsel | Alkermes, Inc. (ALKS) | 08-Jul-11 | Payment of Exercise | 2,088 | $19.52 | $40,757.80 | (6%) 34.55K to 32.46K | (46%) |
08-Jul-11 8:45 AM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 06-Jul-11 | Market Option Sale (Planned) | 15,000 | $18.69 | $280,316.00 | (37%) 40.62K to 25.61K | (52%) |
08-Jul-11 8:45 AM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 06-Jul-11 | Option Exercise | 15,000 | $8.55 | $128,250.00 | 59% 25.61K to 40.62K | |
05-Jul-11 4:25 PM View: | Breyer Robert A Director | Alkermes, Inc. (ALKS) | 01-Jul-11 | Market Option Sale (Planned) | 3,025 | $18.55 | $56,113.70 | (5%) 67.18K to 64.16K | (53%) |
01-Jul-11 4:15 PM View: | Bloom Floyd E Director | Alkermes, Inc. (ALKS) | 01-Jul-11 | Market Sale (Planned) | 10,000 | $18.63 | $186,264.00 | (8%) 130.38K to 120.38K | (53%) |
05-Jul-11 4:20 PM View: | Biberstein Kathryn L SVP, General Counsel | Alkermes, Inc. (ALKS) | 01-Jul-11 | Option Exercise | 100,000 | $7.69 | $769,000.00 | 289% 34.55K to 134.55K | |
05-Jul-11 4:20 PM View: | Biberstein Kathryn L SVP, General Counsel | Alkermes, Inc. (ALKS) | 01-Jul-11 | Market Option Sale (Planned) | 100,000 | $19.00 | $1,900,070.00 | (74%) 134.55K to 34.55K | (50%) |
05-Jul-11 4:25 PM View: | Breyer Robert A Director | Alkermes, Inc. (ALKS) | 01-Jul-11 | Option Exercise | 3,025 | $7.19 | $21,749.80 | 5% 64.16K to 67.18K | |
05-Jul-11 4:25 PM View: | Breyer Robert A Director | Alkermes, Inc. (ALKS) | 01-Jul-11 | Market Sale (Planned) | 3,025 | $18.55 | $56,113.70 | (5%) 64.16K to 61.13K | (53%) |
01-Jul-11 4:15 PM View: | Bloom Floyd E Director | Alkermes, Inc. (ALKS) | 30-Jun-11 | Market Sale (Planned) | 10,000 | $18.14 | $181,357.00 | (7%) 140.38K to 130.38K | (57%) |
01-Jul-11 4:12 PM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 29-Jun-11 | Option Exercise | 12,000 | $7.36 | $88,320.00 | 47% 25.61K to 37.62K | |
01-Jul-11 4:12 PM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 29-Jun-11 | Market Option Sale (Planned) | 12,000 | $17.80 | $213,602.00 | (32%) 37.62K to 25.61K | (60%) |
28-Jun-11 4:10 PM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 24-Jun-11 | Market Option Sale (Planned) | 4,000 | $17.46 | $69,830.40 | (14%) 29.61K to 25.61K | (63%) |
28-Jun-11 4:14 PM View: | Frates James M SVP, CFO & Treasurer | Alkermes, Inc. (ALKS) | 24-Jun-11 | Gift | 995 | -- | -- | (1%) 91.19K to 90.19K | |
28-Jun-11 4:10 PM View: | Pugh Gordon G SVP & COO | Alkermes, Inc. (ALKS) | 24-Jun-11 | Option Exercise | 4,000 | $4.77 | $19,080.00 | 16% 25.61K to 29.61K | |
02-Jun-11 4:07 PM View: | Ehrich Elliot SVP, R&D & Chief Medical Ofcr | Alkermes, Inc. (ALKS) | 02-Jun-11 | Market Sale (Planned) | 1,023 | $17.80 | $18,209.40 | (5%) 19.6K to 18.58K | (60%) |
02-Jun-11 4:25 PM View: | Breyer Robert A Director | Alkermes, Inc. (ALKS) | 01-Jun-11 | Option Exercise | 3,025 | $7.19 | $21,749.80 | 5% 67.18K to 70.21K | |
02-Jun-11 4:07 PM View: | Ehrich Elliot SVP, R&D & Chief Medical Ofcr | Alkermes, Inc. (ALKS) | 01-Jun-11 | Payment of Exercise | 477 | $17.87 | $8,523.99 | (2%) 20.08K to 19.6K | (59%) |
02-Jun-11 4:03 PM View: | Frates James M SVP, CFO & Treasurer | Alkermes, Inc. (ALKS) | 01-Jun-11 | Payment of Exercise | 596 | $17.87 | $10,650.50 | (< 1%) 91.78K to 91.19K | (59%) |
02-Jun-11 4:10 PM View: | Landine Michael J SVP, Corporate Development | Alkermes, Inc. (ALKS) | 01-Jun-11 | Payment of Exercise | 626 | $17.87 | $11,186.60 | (< 1%) 151.91K to 151.29K | (59%) |
02-Jun-11 4:16 PM View: | Pops Richard F President and CEO Director | Alkermes, Inc. (ALKS) | 01-Jun-11 | Payment of Exercise | 2,610 | $17.87 | $46,640.70 | (< 1%) 431.14K to 428.53K | (59%) |
02-Jun-11 4:25 PM View: | Breyer Robert A Director | Alkermes, Inc. (ALKS) | 01-Jun-11 | Market Option Sale (Planned) | 3,025 | $18.13 | $54,843.20 | (4%) 70.21K to 67.18K | (57%) |